Skip to Content

Tag: Henry Schein


Also Noted

Henry Schein to change board make-up

April 8, 2026HME News Staff

MELVILLE, N.Y. – Henry Schein will reduce the size of its board of directors and designate Stanley Bergman as chairman emeritus during its 2026 Annual Meeting of Stockholders on May 21, 2026. Bergman is retiring after 45 years at Henry Schein. In addition, Joseph L. Herring, Robert J. Hombach, Scott Serota, and Bradley T. Sheares will not stand for reelection at the meeting. Accordingly, the board has approved a reduction in size from 15 to 10 members. The incumbent directors nominated for...

Henry Schein, Stanley M. Bergman


Read Full Articlered right arrow icon

Fred Lowery

Also Noted

Henry Schein names new CEO 

January 12, 2026HME News Staff

MELVILLE, N.Y. - Henry Schein has named Frederick M. Lowery as its new CEO effective March 2, 2026. He will also join the company’s board of directors at that time. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years but will continue to serve as chairman of the board to ensure a smooth and effective leadership transition. Lowery brings more than two decades of health care expertise to Henry Schein, with a strong track record of...

Frederick Lowery, Henry Schein


Read Full Articlered right arrow icon

Also Noted

Henry Schein provides update on search for new CEO 

December 29, 2025HME News Staff

MELVILLE, N.Y. – Henry Schein expects to appoint its next CEO by mid-January 2026. The company says it has nearly completed the search process, but it will not be finalized before year-end. “We have evaluated a pool of highly qualified candidates, and the level of interest and caliber of talent have been exceptional,” said Philip A. Laskawy, lead director for Henry Schein. “We expect to make a final decision on a...

Chief Executive Officer (CEO), Henry Schein


Read Full Articlered right arrow icon

Practice Pink

Also Noted

Henry Schein kicks off Practice Pink to advance cancer prevention 

October 6, 2025HME News Staff

MELVILLE, N.Y. - Henry Schein has kicked off its Practice Pink program, an annual global initiative aimed at raising awareness and supporting efforts to prevent, detect and treat cancer. As part of the program, the company offers dental and medical health care professionals a variety of pink products, including health care consumables, practice supplies and apparel. “At Henry Schein, we believe collective action can make a difference in the lives of individuals and families impacted by cancer,”...

cancer prevention, Henry Schein, Home medical supplies, Practice Pink


Read Full Articlered right arrow icon

News

In brief: O&P finalists, KabaFusion deal, Apple update

August 20, 2025HME News Staff

WATERLOO, Iowa – The Orthotic and Prosthetic Group of America (OPGA) has announced the finalists for the 2025 O&P Woman of the Year Award. They are:  Fanny Schultea, MS, MSEd, CPO, LP, FAAOP(D), executive director, The Orthotics and Prosthetics Foundation for Education and Research;  Lesleigh Sisson, CFO, CFm, vice president & general manager, O&P Insight;  Arlene Gillis, founder and president, International Institute of Orthotics and Prosthetics;...

Apple, Henry Schein, Inc. 5000, KabaFusion, Orthotic & Prosthetic Group of America (OPGA), Ottobock, Prochant


Read Full Articlered right arrow icon

News

In brief: CMS’s diabetes proposal, plus people news from AAH, ADS, Henry Schein

July 16, 2025HME News Staff

WASHINGTON – CMS is proposing changing the Medicare Diabetes Prevention Program to allow more people to access coaching and peer support, as well as practical training in dietary change, physical activity and behavior change strategies, to delay or prevent the onset of Type 2 diabetes for those with prediabetes.  In a new proposed rule, the agency also seeks to remove 10 quality measures that it says did not improve health outcomes and add five new measures that focus on the prevention...

AAHomecare, Advanced Diabetes Supply (ADS), chronic disease management, Diabetes, Henry Schein


Read Full Articlered right arrow icon

Also Noted

Henry Schein CEO to retire 

July 15, 2025HME News Staff

MELVILLE, N.Y. - Henry Schein CEO Stanley M. Bergman will retire at the end of the year after 45 years at the company, including more than 35 years in the top role. He will continue to lead the company until his retirement and will remain chairman of the board following his retirement. “With the progress made advancing our BOLD+1 strategic plan and with strong management in place, it is the right time for me to retire at the end of the year,” Mr. Bergman said. “I look forward to...

Henry Schein, Stanley M. Bergman


Read Full Articlered right arrow icon

Also Noted

Henry Schein completes investment, names new board members 

May 19, 2025HME News Staff

MELVILLE, N.Y. - Henry Schein has announced the completion of a $250 million strategic investment by funds affiliated with KKR, making the investment firm a holder of about 12% of the common shares of the company, and the appointment of William K. “Dan” Daniel as an independent director. Daniel is an executive advisor to KKR and a former executive vice president of Danaher Corp. He joins Max Lin, partner at KKR and leader of the firm’s health care industry team in the Americas,...

Board of Directors, Henry Schein, KKR


Read Full Articlered right arrow icon

Also Noted

Henry Schein advances BOLD plan 

May 5, 2025HME News Staff

MELVILLE, N.Y. - Henry Schein has reported total net sales of $3.2 billion for the first quarter 2025, with constant currency total net sales increasing 1.4% compared with the same period last year, and as-reported total net sales decreasing 0.1% due to a stronger U.S. dollar. Global Distribution and Value-Added Services sales increased 0.8% in constant currencies. Of that, Global Medical Distribution sales increased 3%, reflecting increased patient traffic to physician offices, strong growth in...

2025, Financial Results, First Quarter (Q1), Henry Schein


Read Full Articlered right arrow icon

Adam Bries

Specialty Providers

Henry Schein makes advance in ‘particularly attractive’ CGM market 

March 14, 2025Theresa Flaherty, Managing Editor

MELVILLE, N.Y. – The combination of Henry Schein’s distribution capabilities with Acentus’ technology expertise will pack a one-two punch as they position themselves for future growth in the competitive diabetes market, the companies say. Henry Schein closed recently on its acquisition of the Tampa, Fla.-based Acentus, a national supplier specializing in CGMs, in a deal that broadened its portfolio of home medical supply products. “Acentus really enhances and integrates...

Acentus, Continuous Glucose Monitor (CGM), Henry Schein, Medical supplies


Read Full Articlered right arrow icon